Volume 11, Number 8—August 2005
Research
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Kepler A. Davis*
, Kimberly A. Moran†, C. Kenneth McAllister*, and Paula J. Gray*
, Kimberly A. Moran†, C. Kenneth McAllister*, and Paula J. Gray*
Table 4
Acinetobacter calcoaceticus-baumannii complex antimicrobial drug susceptibilities for 38 isolates recovered from wound or blood cultures
| Antimicrobial drug | Susceptible (%) |
|---|---|
| Amikacin | 48 |
| Amoxicillin/clavulanate | 9 |
| Ampicillin/sulbactam | 50 |
| Cefepime | 14 |
| Cefotetan | 3 |
| Ceftazidime | 12 |
| Ceftriaxone | 6 |
| Ciprofloxacin | 11 |
| Colistin* | 100 |
| Gentamicin | 8 |
| Imipenem | 89 |
| Tobramycin | 14 |
| Trimethoprim/sulfamethoxazole | 29 |
*Colistin susceptibility evaluated in 3 multidrug-resistant isolates.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.